The Cigna Group (NYSE:CI – Get Free Report) will be announcing its earnings results before the market opens on Thursday, October 31st. Analysts expect the company to announce earnings of $7.22 per share for the quarter. The Cigna Group has set its FY 2024 guidance at 28.400- EPS and its FY24 guidance at at least $28.40 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.
The Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.42 by $0.30. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm had revenue of $60.52 billion for the quarter, compared to analyst estimates of $58.30 billion. During the same quarter in the prior year, the company earned $6.13 EPS. The Cigna Group’s revenue was up 24.6% on a year-over-year basis. On average, analysts expect The Cigna Group to post $28 EPS for the current fiscal year and $32 EPS for the next fiscal year.
The Cigna Group Trading Up 0.0 %
NYSE CI opened at $317.61 on Thursday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market cap of $90.22 billion, a price-to-earnings ratio of 26.08, a PEG ratio of 1.05 and a beta of 0.50. The firm has a 50 day simple moving average of $349.85 and a 200-day simple moving average of $343.40. The Cigna Group has a one year low of $253.95 and a one year high of $370.83.
The Cigna Group Dividend Announcement
Analysts Set New Price Targets
CI has been the topic of a number of recent research reports. Royal Bank of Canada restated an “outperform” rating and set a $384.00 target price on shares of The Cigna Group in a research note on Monday, September 9th. Barclays raised their price target on The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 2nd. JPMorgan Chase & Co. upped their price target on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. Finally, Jefferies Financial Group raised their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $392.79.
Check Out Our Latest Analysis on CI
Insider Activity
In related news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at $6,010,264.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.60% of the company’s stock.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
- Five stocks we like better than The Cigna Group
- Best Stocks Under $10.00
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Manufacturing Stocks Investing
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.